451 related articles for article (PubMed ID: 34233172)
1. Sphingolipids in metabolic disease: The good, the bad, and the unknown.
Green CD; Maceyka M; Cowart LA; Spiegel S
Cell Metab; 2021 Jul; 33(7):1293-1306. PubMed ID: 34233172
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids: players in the pathology of metabolic disease.
Cowart LA
Trends Endocrinol Metab; 2009 Jan; 20(1):34-42. PubMed ID: 19008117
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL; Summers SA
Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.
Oskouian B; Saba J
Cell Cycle; 2007 Mar; 6(5):522-7. PubMed ID: 17361098
[TBL] [Abstract][Full Text] [Related]
5. ORMDL in metabolic health and disease.
Brown RDR; Spiegel S
Pharmacol Ther; 2023 May; 245():108401. PubMed ID: 37003301
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
Kihara A
Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042
[TBL] [Abstract][Full Text] [Related]
7. Click reactions with functional sphingolipids.
Fink J; Seibel J
Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
Iqbal J; Walsh MT; Hammad SM; Hussain MM
Trends Endocrinol Metab; 2017 Jul; 28(7):506-518. PubMed ID: 28462811
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids and glycerophospholipids - The "ying and yang" of lipotoxicity in metabolic diseases.
Rodriguez-Cuenca S; Pellegrinelli V; Campbell M; Oresic M; Vidal-Puig A
Prog Lipid Res; 2017 Apr; 66():14-29. PubMed ID: 28104532
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
14. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids in cancer.
Furuya H; Shimizu Y; Kawamori T
Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and their metabolism in physiology and disease.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2018 Mar; 19(3):175-191. PubMed ID: 29165427
[TBL] [Abstract][Full Text] [Related]
17. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
18. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver.
Bektas M; Allende ML; Lee BG; Chen W; Amar MJ; Remaley AT; Saba JD; Proia RL
J Biol Chem; 2010 Apr; 285(14):10880-9. PubMed ID: 20097939
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids in High Fat Diet and Obesity-Related Diseases.
Choi S; Snider AJ
Mediators Inflamm; 2015; 2015():520618. PubMed ID: 26648664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]